Search clinical trials for: Adrenergic beta-2 Receptor Agonists
Total 9854 results
-
Mansoura UniversityUnknownProstatic Neoplasms | Erectile Dysfunction | BPH | Prostate Hyperplasia | Erectile AbnormalitiesEgypt
-
Fundación Centro Nacional de Investigaciones Cardiovasculares...Hospital Clinic of Barcelona; Fundació Institut de Recerca de l'Hospital de... and other collaboratorsUnknownHeart Failure | Pulmonary Hypertension | Mirabegron | Pulmonary Vascular Resistance Abnormality
-
Karolinska InstitutetCompletedOveractive BladderSweden
-
Astellas Pharma IncCompletedHealthy Volunteers | Pharmacokinetics of MirabegronFrance
-
Astellas Pharma China, Inc.CompletedHealthy Chinese VolunteersChina
-
Hospital KemamanCompleted
-
St. Joseph's Healthcare HamiltonNot yet recruitingOveractive Bladder | Benign Prostatic HyperplasiaCanada
-
Tanta UniversityRecruitingDepth of Anesthesia | Patient's SatisfactionEgypt
-
Novartis PharmaceuticalsSchering-PloughCompletedAsthmaRussian Federation, United Kingdom, Germany, Spain, Czech Republic, Israel, Poland, South Africa, Belgium, Hungary
-
Taipei Veterans General Hospital, TaiwanRecruitingOveractive Bladder SyndromeTaiwan
-
Southern Illinois UniversityAstellas Scientific & Medical Affairs, Inc.; Sisters of the Third Order of...TerminatedPain | Urinary Bladder, Overactive | Lower Urinary Tract SymptomsUnited States
-
University of FloridaNational Institute of General Medical Sciences (NIGMS)TerminatedPulmonary Hypertension | Heart Failure With Preserved Ejection Fraction | Diastolic Heart FailureUnited States
-
The University of Texas Health Science Center at...CompletedCognitive Change | Spinal Cord Injuries | Neurogenic BladderUnited States
-
Loyola UniversityAstellas Pharma US, Inc.Completed
-
Buddhist Tzu Chi General HospitalUnknownOveractive Bladder SyndromeTaiwan
-
Astellas Pharma IncCompletedUrinary Bladder, OveractiveJapan
-
Astellas Pharma IncCompletedOveractive Bladder | Cardiovascular DiseaseJapan
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedIntraocular PressureUnited States
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Mild and Moderate Hepatic ImpairmentSlovakia
-
GlaxoSmithKlineCompletedIrritable Bowel Syndrome (IBS)United States
-
Mylan Bertek PharmaceuticalsCompletedHypertensionUnited States
-
Xinchen WangTibet Autonomous Region People's HospitalCompletedSeptic Shock | Stress Response | Cerebral HemodynamicsChina
-
George Papanicolaou HospitalUnknownIntracranial Aneurysm | Intracranial NeoplasmsGreece
-
Brigham and Women's HospitalCompleted
-
Novartis PharmaceuticalsWithdrawnChronic Obstructive Pulmonary Disease (COPD)
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseasePoland
-
Bispebjerg HospitalHormone Laboratory, Aker University Hospital, Oslo, NorwayUnknown
-
NovartisSchering-PloughCompletedCOPDFrance, Germany, Belgium, Italy, Turkey, Hungary, Argentina, Peru, United Kingdom, South Africa, Latvia, Lithuania, Romania, Chile, Ireland, Norway, Poland
-
Indiana UniversityOffice of Naval Research (ONR)CompletedResting Energy Expenditure | Brown Adipose Tissue | ThermogenesisUnited States
-
Indiana UniversityOffice of Naval Research (ONR)CompletedResting Energy Expenditure | Brown Adipose Tissue | ThermogenesisUnited States
-
Korea University Anam HospitalActive, not recruitingHypertensionKorea, Republic of
-
Astellas Pharma China, Inc.CompletedPharmacokinetics of Mirabegron | Food Effect | Healthy Chinese SubjectsChina
-
Swiss Group for Clinical Cancer ResearchCompletedPrimary Myelofibrosis | Polycythemia Vera | Essential Thrombocythemia | Myeloproliferative NeoplasmSwitzerland
-
CHU de Quebec-Universite LavalCompletedOveractive Bladder | Urinary Incontinence
-
Mercy ResearchForest LaboratoriesCompletedHypertensionUnited States
-
Astellas Pharma IncCompleted
-
Mylan Bertek PharmaceuticalsCompleted
-
Henning BundgaardHvidovre University Hospital; Herlev Hospital; Royal North Shore Hospital; Bispebjerg-Frederiksberg... and other collaboratorsCompletedHeart Failure With Reduced Ejection Fraction NYHA Class III-IVDenmark
-
Far Eastern Memorial HospitalWithdrawnOveractive Bladder SyndromeTaiwan
-
GlaxoSmithKlineCompleted
-
Seoul National University HospitalUnknown
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedOveractive BladderPoland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of MirabegronUnited States
-
Mylan Bertek PharmaceuticalsCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
DeyCompleted
-
Université de SherbrookeLaval UniversityCompleted